Correlation Between Firan Technology and NeuPath Health

Can any of the company-specific risk be diversified away by investing in both Firan Technology and NeuPath Health at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Firan Technology and NeuPath Health into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Firan Technology Group and NeuPath Health, you can compare the effects of market volatilities on Firan Technology and NeuPath Health and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Firan Technology with a short position of NeuPath Health. Check out your portfolio center. Please also check ongoing floating volatility patterns of Firan Technology and NeuPath Health.

Diversification Opportunities for Firan Technology and NeuPath Health

0.17

Correlation Coefficient

Firan Technology  NeuPath Health

Average diversification

The 3 months correlation between Firan and NeuPath is 0.17. Overlapping area represents the amount of risk that can be diversified away by holding Firan Technology Group and NeuPath Health in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on NeuPath Health and Firan Technology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Firan Technology Group are associated (or correlated) with NeuPath Health. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of NeuPath Health has no effect on the direction of Firan Technology i.e., Firan Technology and NeuPath Health go up and down completely randomly.

Pair Corralation between Firan Technology and NeuPath Health

Assuming the 90 days trading horizon Firan Technology Group is expected to generate 0.41 times more return on investment than NeuPath Health. However, Firan Technology Group is 2.45 times less risky than NeuPath Health. It trades about 0.14 of its potential returns per unit of risk. NeuPath Health is currently generating about 0.03 per unit of risk. If you would invest  550.00  in Firan Technology Group on September 22, 2024 and sell it today you would earn a total of  179.00  from holding Firan Technology Group or generate 32.55% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Firan Technology Group  vs.  NeuPath Health

Firan Technology

Risk-Adjusted Performance

18 of 100

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in Firan Technology Group are ranked lower than 18 (%) of all global equities and portfolios over the last 90 days. In spite of very uncertain technical and fundamental indicators, Firan Technology displayed solid returns over the last few months and may actually be approaching a breakup point.

NeuPath Health

Risk-Adjusted Performance

4 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in NeuPath Health are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unfluctuating basic indicators, NeuPath Health showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Firan Technology and NeuPath Health

The main advantage of trading using opposite Firan Technology and NeuPath Health positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Firan Technology position performs unexpectedly, NeuPath Health can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NeuPath Health will offset losses from the drop in NeuPath Health's long position.

The idea behind Firan Technology Group and NeuPath Health pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.